Osseotite® Dental Implant System
ZimVie Germany GmbH · Quelle
Proven Clinical Success
The Osseotite surface has more than 10 years of documentation from numerous global multi-center clinical studies and meta-analyses. Clinical studies on the Osseotite surface continue to document the benefits of increased contact osteogenesis, especially in poor-quality bone.
The Osseotite Implant features an acid-etched surface designed to facilitate osseointegration.
Trabecular Metal Implant Features & Benefits
Comprehensive Clinical Research
One of the most well-researched dental implant surfaces on the market today.
Numerous studies report 98% cumulative success rates.
The Osseotite Surface
Facilitates the Osseointegration process.
Demonstrates high contact of implant with new bone.
Five-year study showed no increased risk of Peri-implantitis vs. a ZimVie hybrid implant.
The Osseotite Surface and the Healing Process
A blood clot attaches to an implant when its fibrin strands become intertwined in an implant's micro-surface features. The strength of the clot/implant attachment depends on how tightly the fibrin strands are entangled in the surface. Fibrin strands are typically sub-micron in diameter. Therefore, for the strongest bond, the implant surface features should create a maze of slightly larger spaces that can tightly capture the fibrin strands. Characterized by a 1 to 3 micron peak-to-peak surface created by a unique acid-etch process, the Osseotite surface features are precisely sized to entangle the fibrin strands of the blood clot.
Produktinformationen
| Hersteller | ZimVie Germany GmbH |
|---|---|
| Key Benefit | Facilitates osseointegration and high bone-to-implant contact |
| Surface Type | Acid-etched surface |
Dokumente
- Osseotite Implant Documented SuccessZV1507 REV A 09/23 (Global, except China)Broschüre
- T3 and Osseotite Implant Restorative ManualZVINST0102 REV D 12/25 (Global)Dokument
- T3 and Osseotite Implant Systems Surgical ManualZVINST0012 REV E 04/26 (Global)Dokument
- L’implant Osseotite® Un succès documentéZV1507FR REV A 09/23 (Global, except China)Broschüre
- Systèmes d’implants T3® et Osseotite® Manuel de composants prothétiquesZVINST0102FR REV D 12/25 (Global)Dokument